longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesLongbridge ProFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge

Dr Reddys Laboratories

RDY

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
  • Weekly Recap | RDY.US +4.73%, a steady climb this week

    Weekly Review·Oct 17, 2026 at 08:02 AM
    RDY+0.78%
  • Novo Nordisk AS files trademark opposition against Dr. Reddy's Olymviq

    Wallstreetcn·Mar 25, 2026 at 01:36 PM
    PBE+1.74%NVO-0.04%
LongbridgeAI
© 2026 Longbridge|Terms of ServicePrivacy Policy